Morgan Stanley Resumes Horizon Pharma (HZNP) at Underweight
Tweet
Share
E-mailGet Alerts HZNP Hot Sheet
Price: $116.30 --0%
Rating Summary:
10 Buy, 11 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 17 | Down: 14 | New: 17
Rating Summary:
10 Buy, 11 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 17 | Down: 14 | New: 17
Join SI Premium – FREE
Morgan Stanley resumed coverage on Horizon Pharma (NASDAQ: HZNP) with an Underweight rating and a price target of $23.00.
For an analyst ratings summary and ratings history on Horizon Pharma click here. For more ratings news on Horizon Pharma click here.
Shares of Horizon Pharma closed at $22.03 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Mizuho Starts Regency Centers (REG) at Neutral
- Morgan Stanley Out Positive on Top Pick TSM (2330:TT) (TSM): 'We believe TSMC will pass through additional costs to customers'
- Benchmark Starts Beacon Roofing Supply (BECN) at Buy
Create E-mail Alert Related Categories
New CoverageRelated Entities
Morgan StanleySign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
